2030年北美静脉疾病治疗市场展望

北美静脉疾病治疗市场分析与洞察

静脉疾病包括腿部、手臂、脑、肺或肾脏、脾脏、肝脏等内脏器官的血栓、深静脉血栓形成、慢性静脉功能不全、静脉曲张和静脉溃疡。该疾病的治疗包括药物治疗、内源性激光消融或射频消融 (RFA)、硬化疗法和手术。

Data Bridge Market Research 分析，北美静脉疾病治疗市场预计到 2030 年将达到 42.8615 亿美元，预测期内复合年增长率为 7.4%。本市场报告还深入介绍了定价分析、专利分析和技术进步。

报告指标	细节
预测期	2023 至 2030 年
基准年	2022
历史岁月	2021 (可定制为 2020-1015)
定量单位	收入（百万美元），定价（美元）
涵盖的领域	按产品类型（硬化疗法注射、消融装置、静脉闭合产品、静脉支架、药物及其他）、疾病类型（深静脉血栓形成 (DVT)、慢性静脉功能不全 (CVI)、肺栓塞、浅表血栓性静脉炎、静脉曲张及其他）、治疗类型（硬化疗法、射频消融疗法、激光治疗、门诊静脉切除术、静脉结扎和剥离、血管成形术或支架置入术、手术、压迫疗法、静脉活性药物、腔静脉过滤器及其他疗法）、最终用户（医院、诊所、门诊手术中心及其他）、分销渠道（直接招标、零售及其他）
覆盖国家	美国、加拿大和墨西哥。
涵盖的市场参与者	其中包括：Abbott、Imricor、Baylis Medical Company, Inc.、Theraclion、Sonablate、plusmedica.de、Boston Scientific Corporation、Olympus Corporation、Smith + Nephew、Cook、Scitech、Carl Zeiss Meditec AG、Teleflexcorporated、Alma Lasers、BD、B.Braun SE、Medtronic、Stryker、Koninklijke Philips NV、Varian Medical Systems、Candela Corporation、Teromo corporation、Angiodynamics、optimed Medizinische Instrumente GmbH、Merit Medical Systems 和 Bolitec Laser 等。

北美静脉疾病治疗市场定义

心脏病发作和中风通常是急性事件，主要由阻塞导致血液流向心脏或大脑的堵塞引起。最常见的原因是供应心脏或大脑的血管内壁堆积脂肪沉积物。中风可能是由脑血管出血或血栓引起的。

血管支架技术的进步、微创手术需求的增加以及老年人口的增加推动了北美市场的发展。此外，各公司正在扩大其产品组合，以提供静脉疾病治疗的最佳服务。消融设备等医疗设备用于微创手术，以去除或切除异常身体组织以达到治疗目的。这些系统利用射频、能量、极冷或激光产生的热量造成轻微烧伤。机器人技术的应用不断增加，以扩大产品应用，并将尖端技术集成到消融设备中，以提高患者安全性和手术效率，这些预计将推动市场的发展。

北美静脉疾病治疗市场动态

本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容：

驱动程序

静脉疾病发病率上升

静脉疾病是指损害体内静脉的疾病。受损的血管壁会阻碍循环系统工作，导致血液在肌肉放松时积聚和回流（向后）。这会导致静脉中积聚异常高压。这种积聚会导致静脉收紧和扭曲、肿胀加剧、瓣膜功能不全加剧、血流缓慢以及可能形成血栓。最后，这种情况会导致各种称为静脉疾病的疾病。

由于各种风险因素，例如老龄化、肥胖、高血压或静脉疾病家族史，静脉疾病患者在全球范围内不断增加，并成为一个重大的社会经济问题。因此，静脉疾病患者数量的增加增加了对静脉疾病治疗的需求，从而推动了北美静脉疾病治疗市场的发展。

生活方式的快速变化导致肥胖，进而引发静脉疾病

吸烟、不健康饮食和缺乏运动等生活方式的改变会导致慢性疾病的发展，尤其是心脏病、中风、糖尿病、肥胖症和代谢综合征，最终导致静脉疾病。

身体活动必不可少，久坐不动的生活方式直接导致许多疾病。久坐不动的生活方式可能导致体重增加、容易疲劳，并出现无法解释的疼痛，从而发展为慢性疾病，包括心血管和静脉疾病，程度从中度、严重甚至危及生命。

根据 ScienceDirect 的文章，在临床上，肥胖肢体的静脉疾病比非肥胖肢体的静脉疾病更严重。因此，由于不健康生活方式的增加，肥胖人口迅速增加，静脉疾病也随之增加。因此，生活方式的快速变化导致肥胖，进而引发静脉疾病，这增加了对静脉疾病治疗的需求，并成为北美静脉疾病治疗市场的驱动因素。

克制

缺乏熟练且经过认证的专业人员

对熟练和认证专业人员的需求是静脉疾病治疗市场的一大制约因素。欧洲静脉疾病病例的增加导致静脉疾病治疗需求增加，但医疗中心熟练专业人员的数量减少阻碍了市场的增长。

慢性静脉疾病 (CVD) 常常被医疗保健专业人员忽视，因为他们不了解该问题的严重程度和影响，并且没有充分认识到原发性和继发性静脉疾病的不同表现。心血管疾病的重要性与患者数量以及其更严重表现的社会经济影响有关。

机会

提高对静脉疾病的认识

药物治疗和生活方式的改变都可用于治疗静脉问题。药物、运动和压力袜对静脉有好处，但有时静脉问题需要更彻底的治疗才能恢复静脉的健康和功能。治疗过程取决于静脉疾病的类型和严重程度。过去几十年来，患有血管疾病的患者数量急剧增加，糖尿病是最明显的风险因素。与其他健康问题不同，大约 80% 的人口不知道血管疾病和血管手术。随着健康意识的增强，人们对特定疾病的态度和行为可能会发生重大变化。

各种协会、政府机构和其他机构都开展了多项宣传计划。他们采取的这些举措将提高人们对健康的认识，并尽早诊断，以便更好地治疗和预防。因此，人们对静脉疾病的认识提高有望成为北美静脉疾病治疗市场需求增长的机会。

挑战

静脉疾病治疗费用高昂

仅在美国，就有超过 2500 万人患有慢性静脉功能不全 (CVI)，其中超过 600 万人患有晚期静脉疾病。由于 CVI 发病率高且医疗费用不断上涨，美国医疗保健系统承受着沉重的财务负担。许多普遍的健康问题都是由静脉循环不良引起的。腿部疼痛、水肿和沉重感是慢性静脉疾病 (CVD) 的一些早期症状，这些症状可能整天都存在，或在晚上变得更加明显。患者经常寻求初步治疗，以治疗可能伴随或不伴随静脉曲张出现的症状，以及美容性静脉曲张去除术。CVD 的两个主要风险因素是年龄增长和体重过重。

COVID-19 后对北美静脉疾病治疗市场的影响

疫情对制造商和用户都产生了不利影响。由于静脉曲张手术不紧急，因此手术量急剧下降。由于旅行限制导致治疗静脉曲张的手术或手术减少，也影响了制造商的销售。

制造商正在制定各种战略决策，以在新冠疫情后实现复苏。参与者正在进行多项研发活动、产品发布和战略合作，以改进宠物食品调味料和配料市场所涉及的技术和测试结果。

最新动态

2022 年 7 月，北美医疗技术公司 Smith+Nephew 推出了临床支持应用程序，以帮助减少伤口护理中的实践差异。WOUND COMPASS 临床支持应用程序是一款面向医疗保健专业人员的综合数字支持工具，可帮助进行伤口评估和决策，以帮助减少实践差异。这有助于该公司吸引医疗保健客户并扩大产品组合
2022 年 4 月，Carl Zeiss Meditec 宣布收购两家手术器械制造商（Kogent Surgical, LLC 和 Katalyst Surgical, LLC），以进一步加强其作为解决方案提供商的地位。这有助于该公司扩大业务

北美静脉疾病治疗市场范围

北美静脉疾病治疗市场细分为产品类型、疾病类型、治疗类型、最终用户和分销渠道。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。

北美静脉疾病治疗市场（按产品类型划分）

消融设备
静脉支架
静脉闭合产品
硬化疗法注射
药物
其他的

根据产品类型，北美静脉疾病治疗市场细分为消融装置、静脉支架、静脉封闭产品、硬化疗法注射、药物等

北美静脉疾病治疗市场（按疾病类型划分）

深静脉血栓形成 (DVT)
慢性静脉功能不全 (CVI)
肺栓塞
浅表血栓性静脉炎
静脉曲张
其他的

根据疾病类型，北美静脉疾病治疗市场细分为深静脉血栓形成 (DVT)、慢性静脉功能不全 (CVI)、肺栓塞、浅表血栓性静脉炎、静脉曲张等

北美静脉疾病治疗市场（按治疗类型划分）

加压疗法
VENO 活性药物
手术
硬化疗法
血管成形术或支架植入术
静脉结扎和剥脱术
下腔静脉过滤器
门诊静脉切除术
射频消融治疗
激光治疗
其他疗法

根据治疗类型，北美静脉疾病治疗市场细分为压迫疗法、静脉活性药物治疗、手术、硬化疗法、血管成形术或支架术、静脉扩张和剥离术、腔静脉滤器、门诊静脉切除术、射频消融治疗、激光治疗和其他疗法

北美静脉疾病治疗市场，按最终用户划分

医院
诊所
门诊手术中心
其他的

根据最终用户，北美静脉疾病治疗市场分为医院、诊所、门诊手术中心和其他

北美静脉疾病治疗市场，按分销渠道划分

直接招标
零售销售
其他的

根据分销渠道，北美静脉疾病治疗市场分为直接招标、零售和其他

北美静脉疾病治疗市场区域分析/见解

对北美静脉疾病治疗市场进行分析，并提供市场规模信息，包括产品类型、疾病类型、治疗类型、最终用户和分销渠道。

本市场报告涵盖的国家包括美国、加拿大和墨西哥。

美国在北美占据主导地位，因为其最大的消费市场拥有主要市场参与者，且 GDP 较高。美国预计将凭借其在静脉疾病治疗领域的最新先进技术和发明实现增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了北美品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战，以及销售渠道的影响。

竞争格局和北美静脉疾病治疗市场份额分析

北美静脉疾病治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对北美静脉疾病治疗市场的关注有关。

北美静脉疾病治疗市场的一些主要参与者包括雅培 (Abbott)、Imricor、Baylis Medical Company, Inc.、Theraclion、Sonablate、plusmedica.de、波士顿科学公司 (Boston Scientific Corporation)、奥林巴斯公司 (Olympus Corporation)、史密斯侄子 (Smith + Nephew)、库克 (Cook)、Scitech、卡尔蔡司医疗公司 (Carl Zeiss Meditec AG)、泰利福公司 (Teleflex corporate)、Alma Lasers、BD、B.Braun SE、美敦力 (Medtronic)、史赛克 (Stryker)、荷兰皇家飞利浦公司 (Koninklijke Philips NV)、瓦里安医疗系统 (Varian Medical Systems)、坎德拉公司 (Candela Corporation)、Teromo corporation、Angiodynamics、optimed Medizinische Instrumente GmbH、Merit Medical Systems 和 Bolitec Laser 等。

SKU-69788

Get online access to the report on the World's First Market Intelligence Cloud

Click on image to enlarge

Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Request for Demo

表格列表

TABLE 1 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 2 NORTH AMERICA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 3 NORTH AMERICA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 4 NORTH AMERICA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 5 NORTH AMERICA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 6 NORTH AMERICA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 7 NORTH AMERICA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 8 NORTH AMERICA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 9 NORTH AMERICA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 10 NORTH AMERICA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 11 NORTH AMERICA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 12 NORTH AMERICA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 13 NORTH AMERICA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 14 NORTH AMERICA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 15 NORTH AMERICA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 16 NORTH AMERICA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 17 NORTH AMERICA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 18 NORTH AMERICA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 19 NORTH AMERICA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 20 NORTH AMERICA ILIAC VEIN STENT TECHNOLOGY IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 21 NORTH AMERICA MEDICATION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 22 NORTH AMERICA OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 23 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)

TABLE 24 NORTH AMERICA VARICOSE VEINS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 25 NORTH AMERICA DEEP VEIN THROMBOSIS (DVT) IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 26 NORTH AMERICA PULMONARY EMBOLISM IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 27 NORTH AMERICA CHRONIC VENOUS INSUFFICIENCY (CVI) IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 28 NORTH AMERICA SUPERFICIAL THROMBOPHLEBITIS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 29 NORTH AMERICA OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 30 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 31 NORTH AMERICA SCELEROTHERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 32 NORTH AMERICA RADIOFREQUENCY ABLATION THERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 33 NORTH AMERICA LASER TREATMENT IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 34 NORTH AMERICA AMBULATORY PHELEBECTOMY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 35 NORTH AMERICA VEIN LIGATION AND STRIPPING IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 36 NORTH AMERICA ANGIOPLASTY OR STENTING IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 37 NORTH AMERICA SURGERIES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 38 NORTH AMERICA COMPRESSION THERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 39 NORTH AMERICA VEINACTIVE MEDICATION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 40 NORTH AMERICA VENA CAVA FILTER IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 41 NORTH AMERICA OTHER THERAPIES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 42 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 43 NORTH AMERICA HOSPITALS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 44 NORTH AMERICA CLINICS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 45 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 46 NORTH AMERICA OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 47 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 48 NORTH AMERICA DIRECT TENDER IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 49 NORTH AMERICA RETAIL SALES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 50 NORTH AMERICA OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 51 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 52 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 53 NORTH AMERICA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 54 NORTH AMERICA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 55 NORTH AMERICA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 56 NORTH AMERICA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 57 NORTH AMERICA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 58 NORTH AMERICA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 59 NORTH AMERICA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 60 NORTH AMERICA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 61 NORTH AMERICA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 62 NORTH AMERICA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 63 NORTH AMERICA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 64 NORTH AMERICA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 65 NORTH AMERICA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 66 NORTH AMERICA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 67 NORTH AMERICA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 68 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)

TABLE 69 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 70 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 71 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 72 U.S. VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 73 U.S. SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 74 U.S. SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 75 U.S. ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 76 U.S. THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 77 U.S. RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 78 U.S. LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 79 U.S. ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 80 U.S. RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 81 U.S. ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 82 U.S. NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 83 U.S. CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 84 U.S. VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 85 U.S. VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 86 U.S. VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 87 U.S. VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 88 U.S. VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)

TABLE 89 U.S. VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 90 U.S. VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 91 U.S. VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 92 CANADA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 93 CANADA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 94 CANADA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 95 CANADA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 96 CANADA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 97 CANADA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 98 CANADA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 99 CANADA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 100 CANADA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 101 CANADA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 102 CANADA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 103 CANADA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 104 CANADA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 105 CANADA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 106 CANADA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 107 CANADA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)

TABLE 108 CANADA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 109 CANADA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 110 CANADA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 111 MEXICO VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 112 MEXICO SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 113 MEXICO SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 114 MEXICO ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 115 MEXICO THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 116 MEXICO RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 117 MEXICO LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 118 MEXICO ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 119 MEXICO RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 120 MEXICO ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 121 MEXICO NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 122 MEXICO CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 123 MEXICO VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 124 MEXICO VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 125 MEXICO VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 126 MEXICO VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 127 MEXICO VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)

TABLE 128 MEXICO VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 129 MEXICO VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 130 MEXICO VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

图片列表

FIGURE 1 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: MARKET END USER COVERAGE GRID

FIGURE 8 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: SEGMENTATION

FIGURE 11 GROWING AWARENESS ABOUT VENOUS DISEASES TREATMENTS AND INCREASING HEALTHCARE EXPENDITURE IS EXPECTED TO DRIVE THE GROWTH OF THE NORTH AMERICA VENOUS DISEASES TREATMENT MARKET FROM 2023 TO 2030

FIGURE 12 THE ABLATION DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA VENOUS DISEASES TREATMENT MARKET IN 2023 & 2030

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE NORTH AMERICA VENOUS DISEASES TREATMENT MARKET

FIGURE 14 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, 2022

FIGURE 15 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, 2023-2030 (USD MILLION)

FIGURE 16 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, CAGR (2023-2030)

FIGURE 17 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 18 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, 2022

FIGURE 19 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, 2023-2030 (USD MILLION)

FIGURE 20 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, CAGR (2023-2030)

FIGURE 21 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, LIFELINE CURVE

FIGURE 22 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, 2022

FIGURE 23 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, 2023-2030 (USD MILLION)

FIGURE 24 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, CAGR (2023-2030)

FIGURE 25 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, LIFELINE CURVE

FIGURE 26 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY END USER, 2022

FIGURE 27 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 28 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY END USER, CAGR (2023-2030)

FIGURE 29 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY END USER, LIFELINE CURVE

FIGURE 30 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, 2022

FIGURE 31 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 32 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 33 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 34 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: SNAPSHOT (2022)

FIGURE 35 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022)

FIGURE 36 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2023 & 2030)

FIGURE 37 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022 & 2030)

FIGURE 38 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: PRODUCT TYPE (2023-2030)

FIGURE 39 NORTH AMERICA VENOUS DISEASES TREATMENT MARKET: COMPANY SHARE 2022 (%)

查看详细信息

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

What is the forecasted growth of this market?

The North America Venous Diseases Treatment Market surges a CAGR of 7.4% by 2030

What will be the market value in the future?

The North America Venous Diseases Treatment Market bags $4,286.15 million by 2030

Which market segments are covered in this report?

The North America Venous Diseases Treatment Market report is segmented by product type, disease type, treatment type, end user, and distribution channel.

Which countries data are covered in the report?

The North America Venous Diseases Treatment Market report analyses these countries U.S., Canada, and Mexico.

Forecast Period	2024 –2030
Market Size (Base Year)	USD MILLION Request
Market Size (Forecast Year)	USD 4,286.15
CAGR	7.40 %
Major Markets Players	Dummy1 Dummy2 Dummy3 Dummy4 Dummy5 Request For Unlock

北美静脉疾病治疗市场 – 行业趋势和 2030 年预测

北美静脉疾病治疗市场 – 行业趋势和 2030 年预测

North America Venous Diseases Treatment Market

CAGR : 7.40 %

北美静脉疾病治疗市场分析与洞察

北美静脉疾病治疗市场定义

北美静脉疾病治疗市场动态

COVID-19 后对北美静脉疾病治疗市场的影响

北美静脉疾病治疗市场范围

北美静脉疾病治疗市场区域分析/见解

竞争格局和北美静脉疾病治疗市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

Frequently Asked Questions

报告

市场洞察

支持

解决方案

北美静脉疾病治疗市场 – 行业趋势和 2030 年预测

北美静脉疾病治疗市场 – 行业趋势和 2030 年预测

North America Venous Diseases Treatment Market

CAGR : 7.40 %

北美静脉疾病治疗市场分析与洞察

北美静脉疾病治疗市场定义

北美静脉疾病治疗市场动态

COVID-19 后对北美静脉疾病治疗市场的影响

北美静脉疾病治疗市场范围

北美静脉疾病治疗市场区域分析/见解

竞争格局和北美静脉疾病治疗市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

Frequently Asked Questions

浏览相关页面